EDESA BIOTECH EDSA 深 沪
等待开盘 11-07 09:30:00 美东时间
1.69
0.000
0.00%
华盛通- 最 高1.72
- 今 开1.65
- 成交量 5.10万股
- 最 低 1.65
- 昨 收 1.69
- 总市值 1186.84万
- 52周最高 4.4899
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.55
- 委 比 -43.34%
- 总股本 702.27万
- 历史最高 133.70
- 量 比 0.29
- 振 幅 4.14%
- 历史最低 1.55
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) stock increased by 36.4% to $0.3 during Fri...
11-01 05:07
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
Edesa Biotech announced positive Phase 3 results for paridiprubart in treating ARDS, showing a 25% relative reduction in mortality risk and a 41% higher rate of clinical improvement. The drug met primary and secondary endpoints, demonstrated durable survival benefits, and was well-tolerated. It has potential for standard-of-care treatment in ARDS and chronic respiratory conditions, supported by funding from the Canadian government.
10-28 11:45
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
Edesa Biotech (($EDSA)), Inflarx N.V. (($IFRX)) announced an update on their on...
10-28 07:50
Edesa Biotech Amends Agreement with Canadian Government
Edesa Biotech ( ($EDSA) ) has issued an announcement. On September 30, 2025, Ed...
10-01 04:27
Edesa Biotech Launches At-The-Market Offering Program
An announcement from Edesa Biotech ( ($EDSA) ) is now available. On September 9...
09-10 05:00
氪星晚报 ｜霸王茶姬正式进入菲律宾市场；宇树科技宣布将在四季度提交IPO申请；金价迭创新高，多家黄金企业半年净利润翻倍
大公司： “应帆科技”完成亿元A轮融资 36氪获悉，9月1日，“应帆科技”宣布完成亿元级战略A轮融资。此轮投资人涵盖政府产业引导基金、多元产业投资机构，以及科技...
09-02 21:04
三店同开，霸王茶姬正式进入菲律宾市场
日前，霸王茶姬在菲律宾的三家门店同时开业，首次进入菲律宾市场。据了解，这三家门店分别位于SM North EDSA、Robinsons Galleria和...
09-02 16:20
霸王茶姬联手蓝海资本，追加投资加速全球化布局
（来源：辰珵） 三店齐开，文化出海提速，中国新茶饮迈向全球化新阶段 【2025年8月，马尼拉讯】—— 继凤凰网报道的霸王茶姬与蓝海资本战略合作后，双方再次释放...
08-24 06:16
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
Edesa Biotech ( ($EDSA) ) has provided an announcement. Edesa Biotech reported ...
08-09 07:02
Edesa Biotech Q3 EPS $(0.25) Beats $(0.29) Estimate
Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 51.92 percent increase over losses of $(0.52) per share from the
08-09 04:36
